Data from lowest dose level cohorts demonstrate a favorable safety and efficacy profileData includes complete results from ...

In a subset of patients in a 48-week extension trial, the mean duration of the first treatment-free interval was ...

The FDA approved tapinarof cream 1% (Vtama) for eczema in individuals ages 2 years and older, drugmaker Organon announced on ...

The US Food and Drug Administration (FDA) has approved nemolizumab for moderate-to-severe atopic dermatitis inadequately ...

The U.S. Food and Drug Administration has approved Nemluvio (nemolizumab) for the treatment of moderate-to-sev ...

China: A recent analysis from the National Health and Nutrition Examination Survey (NHANES) 2005–2006 revealed that ...

According to newly published research, the exposure to nature provided by the Re-Connecting Nature forest microbe extract has ...

The FDA has blessed two previously approved medicines—one a cream and the other an injection—to treat atopic dermatitis (AD).

Parents of children with eczema are more likely to be short on sleep and to use medication to try to get more of it, a ...

Atopic dermatitis in infancy is associated with an increased risk of developing subsequent atopic march conditions such as allergy or asthma.

Zenrelia is indicated for control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age. Read the entire package insert before using this ...

This latest approval is the second indication of the monoclonal antibody, Nemluvio. It was first approved in Aug. 2024 to ...